Synthesis and Characterization of Glycomaterials for Antibacterial Applications

Every year, millions of people contract antibiotic-resistant bacterial infections, and tens of thousands die from infection-related complications in the United States alone. Bacterial infections are one of the leading causes of death worldwide, especially in healthcare institutes such as hospitals and nursing homes where people are more susceptible to infection and complications. Bacteria can cause infections in any part of the body and often interact with sugar molecules on the surface of cells; once bacteria are attached, the cells stop functioning properly. When a bacterial infection is suspected, samples from the patient's blood or urine are taken to confirm the diagnosis. If the bacterial infection is sever enough, patients are treated with broad-spectrum antibiotics before the type of bacteria is known, and once it has been identified they are given antibiotics that target the specific bacterial strain. The high death rate associated with bacterial infections is largely due to the emergence of antibiotic-resistant bacterial strains. Although antibiotic resistance is present in some naturally occurring bacterial strains, misuse and over-prescription of antibiotics have accelerated the process. To combat the ever-growing threat of antibiotic-resistant bacteria, antibacterial polymers have been developed. Antibacterial polymers prevent bacterial infections by either killing the bacteria themselves or by preventing them from interacting with the body altogether This dissertation primarily focuses on using sugar-containing polymers to prevent bacterial growth. These materials may potentially be used as a replacement for or supplement to traditional antibiotics.